In the breast cancer BM cohort, all seven CTC positive patients showed a mostly strong or intermediate expression for CD74 (39/40 CTCs, Figure 2B) as well as for CD44 (3/40 CTCs, Figure 2C). The gene discussed is CD74; the disease is breast carcinoma.